Psychiatry and clinical psychopharmacologyAug 28, 2025

New Psychotherapy Methods for PTSD Beyond Fear-Focused Treatments

Psychedelic Science Weekly Brief ↗PubMed ↗DOI ↗

Updated Jun 27, 2026

Abstract

Essence

Emerging PTSD psychotherapies are moving beyond a fear-based model toward memory, somatic, moral injury, identity, spirituality, technology-assisted, and multimodal approaches.

Evidence

This narrative review searched MEDLINE and APA PsycINFO through June 29, 2024 for English-language human clinical studies, guidelines, and reviews on therapist-delivered PTSD psychotherapies not yet endorsed by guidelines.

Caveat

The review thematically maps emerging approaches rather than proving them, and it calls for randomized trials with diverse populations and long-term follow-up.

Simplified

Traditional trauma-focused psychotherapies (TFPs) were developed based on an anxiety disorder model of posttraumatic stress disorder (PTSD). However, PTSD is a more complex disorder with heterogeneous onset, presentation, trajectory, and treatment responsivity. As half of treated patients do not respond to first-line treatments, innovative therapies are emerging to improve outcomes. This narrative review of therapist-delivered psychotherapies for PTSD focuses on interventions not yet endorsed by clinical guidelines. A systematic search of MEDLINE and American Psychological Association PsycINFO was conducted for English-language human clinical studies, guidelines, and reviews related to PTSD psychotherapy through June 29, 2024. Data were thematically analyzed, focusing on how emerging interventions modify or diverge from current guideline-recommended treatments. The review identified 4 key themes for improving trauma therapy: (1) optimizing existing TFPs, (2) adapting psychotherapies used for other conditions, (3) reimagining exposure therapies, and (4) new therapeutic modalities. New exposure treatments include those capitalizing on memory reconsolidation science, combination with pharmacotherapies, neuromodulation, or virtual reality technologies, and mind-body and somatic psychotherapies. Moral injury, identity, and spirituality-focused therapies aim to resolve intense internal conflicts, guilt and shame, and issues of meaning and purpose. Finally, multi-modal treatments like 3MDR and psychedelic-assisted psychotherapies have multiple synergistic mechanisms. Ongoing research will be crucial to validating emerging approaches and optimizing their combined potential. A PTSD staging model may provide a structured framework for rigorous empirical evaluation and clinical implementation. Future research should prioritize randomized controlled trials with diverse patient populations and long-term follow-up to ensure their safety, efficacy, and scalability.

Funding

Competing interests

Declaration of Interests: Eric Vermetten is an Associate Editor at Psychiatry and Clinical Psychopharmacology, however, his involvement in the peer-review process was solely as an author. JS has received honoraria for speaking and/or advisory boards from Abbvie, Bausch, Eisai, Idorsia, Janssen, Lundbeck, Otsuka, and Novonordisk. LB and OW are supported by the Academic Medicine and Health Services Program (AMHSP), a joint program funded by the University of Alberta and Alberta Health Services to ensure physicians affiliated with Alberta’s faculties of medicine are compensated for providing patient care along with their work related to research, innovation, education, administration, and leadership. VB is supported by an Academic Scholar Award from the University of Toronto Department of Psychiatry and has received research support from the Canadian Institutes of Health Research, Brain & Behavior Foundation, Ontario Ministry of Health Innovation Funds, Royal College of Physicians and Surgeons of Canada, Department of National Defense (Government of Canada), New Frontiers in Research Fund, Associated Medical Services Inc. Healthcare, American Foundation for Suicide Prevention, Roche Canada, Novartis, and Eisai.

PubMed